Back to Results

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

Study category: Brain and Nervous System

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Observational

Location

University of Colorado Hospital

Principal Investigator
John Corboy,  MD, MA

John Corboy, MD, MA

Study ID

Protocol Number: 20-2772

More information available at ClinicalTrials.gov: NCT04754542

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers